APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lansoprazole

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lansoprazole Market Outlook and Growth Opportunities 2026

20 December 2025201 pages

Choose your research edition.

Industry ResearchLansoprazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Lansoprazole Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Lansoprazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lansoprazole Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Lansoprazole Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Lansoprazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lansoprazole market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lansoprazole market include Takeda Pharmaceutical, Teva Pharms, Suzhou YUSHI Pharmaceutical Co., Sandoz, Nang Kuang Pharmaceutical, Mylan, Luoxin Biotechnology, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lansoprazole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lansoprazole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lansoprazole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lansoprazole market size, projected growth trends, production technologies, key applications, and end-use industries.

Lansoprazole Segment by Company

Takeda Pharmaceutical

Teva Pharms

Suzhou YUSHI Pharmaceutical Co.

Sandoz

Nang Kuang Pharmaceutical

Mylan

Luoxin Biotechnology

Pfizer

GSK

Changzhou Siyao Pharmaceuticals

Beijing Honglin Pharma.

Youcare Pharmaceutical Group

Taj Pharma

Sun Pharmaceutical Industries

Lepu Pharmaceuticals

Krka

HOPE PHARMA

Dr. Reddy's

Cisen Pharmaceutical

Lansoprazole Segment by Type

Injection

Tablets

Capsules

Lansoprazole Segment by Application

Male

Female

Lansoprazole Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Lansoprazole status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lansoprazole market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lansoprazole significant trends, drivers, influence factors in global and regions.

6. To analyze Lansoprazole competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lansoprazole market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lansoprazole industry.

Chapter 3: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lansoprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lansoprazole in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lansoprazole Industry Trends Table 2. Lansoprazole Industry Drivers Table 3. Lansoprazole Industry Opportunities and Challenges Table 4. Lansoprazole Industry Restraints Table 5. Global Lansoprazole Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lansoprazole Revenue Share by Company (2021-2026) Table 7. Global Lansoprazole Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Lansoprazole Sales Volume Share by Company (2021-2026) Table 9. Global Lansoprazole Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lansoprazole Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lansoprazole Key Company Manufacturing Base & Headquarters Table 12. Global Lansoprazole Company, Product Type & Application Table 13. Global Lansoprazole Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lansoprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Tablets Table 19. Significant Companies of Capsules Table 20. Global Lansoprazole Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Lansoprazole Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Lansoprazole Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Lansoprazole Sales Volume Share by Type (2021-2026) Table 24. Global Lansoprazole Sales Volume Share by Type (2027-2032) Table 25. Global Lansoprazole Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lansoprazole Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Lansoprazole Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Lansoprazole Sales Value Share by Type (2021-2026) Table 29. Global Lansoprazole Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Male Table 31. Significant Companies of Female Table 32. Global Lansoprazole Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Lansoprazole Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Lansoprazole Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Lansoprazole Sales Volume Share by Application (2021-2026) Table 36. Global Lansoprazole Sales Volume Share by Application (2027-2032) Table 37. Global Lansoprazole Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lansoprazole Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lansoprazole Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lansoprazole Sales Value Share by Application (2021-2026) Table 41. Global Lansoprazole Sales Value Share by Application (2027-2032) Table 42. Global Lansoprazole Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Lansoprazole Sales by Region (2021-2026) & (W Units) Table 44. Global Lansoprazole Sales Market Share by Region (2021-2026) Table 45. Global Lansoprazole Sales by Region (2027-2032) & (W Units) Table 46. Global Lansoprazole Sales Market Share by Region (2027-2032) Table 47. Global Lansoprazole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lansoprazole Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lansoprazole Sales Value Share by Region (2021-2026) Table 50. Global Lansoprazole Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lansoprazole Sales Value Share by Region (2027-2032) Table 52. Global Lansoprazole Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lansoprazole Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lansoprazole Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Lansoprazole Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lansoprazole Sales by Country (2021-2026) & (W Units) Table 57. Global Lansoprazole Sales Market Share by Country (2021-2026) Table 58. Global Lansoprazole Sales by Country (2027-2032) & (W Units) Table 59. Global Lansoprazole Sales Market Share by Country (2027-2032) Table 60. Global Lansoprazole Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lansoprazole Sales Value Market Share by Country (2021-2026) Table 62. Global Lansoprazole Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lansoprazole Sales Value Market Share by Country (2027-2032) Table 64. Takeda Pharmaceutical Company Information Table 65. Takeda Pharmaceutical Business Overview Table 66. Takeda Pharmaceutical Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Takeda Pharmaceutical Lansoprazole Product Portfolio Table 68. Takeda Pharmaceutical Recent Development Table 69. Teva Pharms Company Information Table 70. Teva Pharms Business Overview Table 71. Teva Pharms Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Teva Pharms Lansoprazole Product Portfolio Table 73. Teva Pharms Recent Development Table 74. Suzhou YUSHI Pharmaceutical Co. Company Information Table 75. Suzhou YUSHI Pharmaceutical Co. Business Overview Table 76. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio Table 78. Suzhou YUSHI Pharmaceutical Co. Recent Development Table 79. Sandoz Company Information Table 80. Sandoz Business Overview Table 81. Sandoz Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sandoz Lansoprazole Product Portfolio Table 83. Sandoz Recent Development Table 84. Nang Kuang Pharmaceutical Company Information Table 85. Nang Kuang Pharmaceutical Business Overview Table 86. Nang Kuang Pharmaceutical Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Nang Kuang Pharmaceutical Lansoprazole Product Portfolio Table 88. Nang Kuang Pharmaceutical Recent Development Table 89. Mylan Company Information Table 90. Mylan Business Overview Table 91. Mylan Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Mylan Lansoprazole Product Portfolio Table 93. Mylan Recent Development Table 94. Luoxin Biotechnology Company Information Table 95. Luoxin Biotechnology Business Overview Table 96. Luoxin Biotechnology Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Luoxin Biotechnology Lansoprazole Product Portfolio Table 98. Luoxin Biotechnology Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Pfizer Lansoprazole Product Portfolio Table 103. Pfizer Recent Development Table 104. GSK Company Information Table 105. GSK Business Overview Table 106. GSK Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. GSK Lansoprazole Product Portfolio Table 108. GSK Recent Development Table 109. Changzhou Siyao Pharmaceuticals Company Information Table 110. Changzhou Siyao Pharmaceuticals Business Overview Table 111. Changzhou Siyao Pharmaceuticals Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio Table 113. Changzhou Siyao Pharmaceuticals Recent Development Table 114. Beijing Honglin Pharma. Company Information Table 115. Beijing Honglin Pharma. Business Overview Table 116. Beijing Honglin Pharma. Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Beijing Honglin Pharma. Lansoprazole Product Portfolio Table 118. Beijing Honglin Pharma. Recent Development Table 119. Youcare Pharmaceutical Group Company Information Table 120. Youcare Pharmaceutical Group Business Overview Table 121. Youcare Pharmaceutical Group Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Youcare Pharmaceutical Group Lansoprazole Product Portfolio Table 123. Youcare Pharmaceutical Group Recent Development Table 124. Taj Pharma Company Information Table 125. Taj Pharma Business Overview Table 126. Taj Pharma Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Taj Pharma Lansoprazole Product Portfolio Table 128. Taj Pharma Recent Development Table 129. Sun Pharmaceutical Industries Company Information Table 130. Sun Pharmaceutical Industries Business Overview Table 131. Sun Pharmaceutical Industries Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Sun Pharmaceutical Industries Lansoprazole Product Portfolio Table 133. Sun Pharmaceutical Industries Recent Development Table 134. Lepu Pharmaceuticals Company Information Table 135. Lepu Pharmaceuticals Business Overview Table 136. Lepu Pharmaceuticals Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Lepu Pharmaceuticals Lansoprazole Product Portfolio Table 138. Lepu Pharmaceuticals Recent Development Table 139. Krka Company Information Table 140. Krka Business Overview Table 141. Krka Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Krka Lansoprazole Product Portfolio Table 143. Krka Recent Development Table 144. HOPE PHARMA Company Information Table 145. HOPE PHARMA Business Overview Table 146. HOPE PHARMA Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. HOPE PHARMA Lansoprazole Product Portfolio Table 148. HOPE PHARMA Recent Development Table 149. Dr. Reddy's Company Information Table 150. Dr. Reddy's Business Overview Table 151. Dr. Reddy's Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Dr. Reddy's Lansoprazole Product Portfolio Table 153. Dr. Reddy's Recent Development Table 154. Cisen Pharmaceutical Company Information Table 155. Cisen Pharmaceutical Business Overview Table 156. Cisen Pharmaceutical Lansoprazole Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Cisen Pharmaceutical Lansoprazole Product Portfolio Table 158. Cisen Pharmaceutical Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Lansoprazole Distributors List Table 162. Lansoprazole Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Lansoprazole Product Image Figure 2. Global Lansoprazole Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lansoprazole Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lansoprazole Sales (2021-2032) & (W Units) Figure 5. Global Lansoprazole Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lansoprazole Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Tablets Image Figure 11. Capsules Image Figure 12. Global Lansoprazole Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Lansoprazole Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Lansoprazole Sales Volume Share by Type (2021-2032) Figure 15. Global Lansoprazole Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Lansoprazole Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Lansoprazole Sales Value Share by Type (2021-2032) Figure 18. Male Image Figure 19. Female Image Figure 20. Global Lansoprazole Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Lansoprazole Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lansoprazole Sales Volume Share by Application (2021-2032) Figure 23. Global Lansoprazole Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lansoprazole Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lansoprazole Sales Value Share by Application (2021-2032) Figure 26. Global Lansoprazole Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Lansoprazole Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lansoprazole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lansoprazole Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lansoprazole Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lansoprazole Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lansoprazole Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lansoprazole Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lansoprazole Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lansoprazole Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lansoprazole Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lansoprazole Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lansoprazole Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lansoprazole Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lansoprazole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lansoprazole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lansoprazole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lansoprazole Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lansoprazole Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
  • Capsules
Applications
  • Male
  • Female
Companies covered
  • Takeda Pharmaceutical
  • Teva Pharms
  • Suzhou YUSHI Pharmaceutical Co.
  • Sandoz
  • Nang Kuang Pharmaceutical
  • Mylan
  • Luoxin Biotechnology
  • Pfizer
  • GSK
  • Changzhou Siyao Pharmaceuticals
  • Beijing Honglin Pharma.
  • Youcare Pharmaceutical Group
  • Taj Pharma
  • Sun Pharmaceutical Industries
  • Lepu Pharmaceuticals
  • Krka
  • HOPE PHARMA
  • Dr. Reddy's
  • Cisen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lansoprazole Sales Value (2021-2032)
  4. 1.2.2 Global Lansoprazole Sales Volume (2021-2032)
  5. 1.2.3 Global Lansoprazole Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lansoprazole Market Dynamics
  1. 2.1 Lansoprazole Industry Trends
  2. 2.2 Lansoprazole Industry Drivers
  3. 2.3 Lansoprazole Industry Opportunities and Challenges
  4. 2.4 Lansoprazole Industry Restraints
3 Lansoprazole Market by Company
  1. 3.1 Global Lansoprazole Company Revenue Ranking in 2025
  2. 3.2 Global Lansoprazole Revenue by Company (2021-2026)
  3. 3.3 Global Lansoprazole Sales Volume by Company (2021-2026)
  4. 3.4 Global Lansoprazole Average Price by Company (2021-2026)
  5. 3.5 Global Lansoprazole Company Ranking (2024-2026)
  6. 3.6 Global Lansoprazole Company Manufacturing Base and Headquarters
  7. 3.7 Global Lansoprazole Company Product Type and Application
  8. 3.8 Global Lansoprazole Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lansoprazole Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lansoprazole Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lansoprazole Market by Type
  1. 4.1 Lansoprazole Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablets
  4. 4.1.3 Capsules
  5. 4.2 Global Lansoprazole Sales Volume by Type
  6. 4.2.1 Global Lansoprazole Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lansoprazole Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Lansoprazole Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Lansoprazole Sales Value by Type
  10. 4.3.1 Global Lansoprazole Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Lansoprazole Sales Value by Type (2021-2032)
  12. 4.3.3 Global Lansoprazole Sales Value Share by Type (2021-2032)
5 Lansoprazole Market by Application
  1. 5.1 Lansoprazole Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Lansoprazole Sales Volume by Application
  5. 5.2.1 Global Lansoprazole Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lansoprazole Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Lansoprazole Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Lansoprazole Sales Value by Application
  9. 5.3.1 Global Lansoprazole Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Lansoprazole Sales Value by Application (2021-2032)
  11. 5.3.3 Global Lansoprazole Sales Value Share by Application (2021-2032)
6 Lansoprazole Regional Sales and Value Analysis
  1. 6.1 Global Lansoprazole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lansoprazole Sales by Region (2021-2032)
  3. 6.2.1 Global Lansoprazole Sales by Region: 2021-2026
  4. 6.2.2 Global Lansoprazole Sales by Region (2027-2032)
  5. 6.3 Global Lansoprazole Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lansoprazole Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lansoprazole Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lansoprazole Sales Value by Region (2027-2032)
  9. 6.5 Global Lansoprazole Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lansoprazole Sales Value (2021-2032)
  12. 6.6.2 North America Lansoprazole Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lansoprazole Sales Value (2021-2032)
  15. 6.7.2 Europe Lansoprazole Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lansoprazole Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lansoprazole Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lansoprazole Sales Value (2021-2032)
  21. 6.9.2 South America Lansoprazole Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lansoprazole Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lansoprazole Sales Value Share by Country, 2025 VS 2032
7 Lansoprazole Country-level Sales and Value Analysis
  1. 7.1 Global Lansoprazole Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lansoprazole Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lansoprazole Sales by Country (2021-2032)
  4. 7.3.1 Global Lansoprazole Sales by Country (2021-2026)
  5. 7.3.2 Global Lansoprazole Sales by Country (2027-2032)
  6. 7.4 Global Lansoprazole Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lansoprazole Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lansoprazole Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lansoprazole Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lansoprazole Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lansoprazole Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lansoprazole Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lansoprazole Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lansoprazole Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lansoprazole Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lansoprazole Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lansoprazole Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lansoprazole Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lansoprazole Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lansoprazole Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lansoprazole Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lansoprazole Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lansoprazole Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lansoprazole Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lansoprazole Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lansoprazole Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lansoprazole Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lansoprazole Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lansoprazole Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lansoprazole Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lansoprazole Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lansoprazole Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lansoprazole Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lansoprazole Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lansoprazole Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lansoprazole Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lansoprazole Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lansoprazole Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lansoprazole Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lansoprazole Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lansoprazole Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lansoprazole Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lansoprazole Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lansoprazole Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lansoprazole Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lansoprazole Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lansoprazole Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lansoprazole Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lansoprazole Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lansoprazole Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lansoprazole Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lansoprazole Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lansoprazole Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lansoprazole Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lansoprazole Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lansoprazole Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lansoprazole Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lansoprazole Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lansoprazole Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lansoprazole Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lansoprazole Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lansoprazole Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lansoprazole Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lansoprazole Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lansoprazole Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lansoprazole Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lansoprazole Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lansoprazole Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lansoprazole Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lansoprazole Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lansoprazole Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lansoprazole Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lansoprazole Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lansoprazole Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lansoprazole Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lansoprazole Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lansoprazole Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lansoprazole Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lansoprazole Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lansoprazole Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lansoprazole Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lansoprazole Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lansoprazole Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lansoprazole Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lansoprazole Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lansoprazole Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lansoprazole Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lansoprazole Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lansoprazole Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lansoprazole Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lansoprazole Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lansoprazole Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical
  2. 8.1.1 Takeda Pharmaceutical Company Information
  3. 8.1.2 Takeda Pharmaceutical Business Overview
  4. 8.1.3 Takeda Pharmaceutical Lansoprazole Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Recent Developments
  7. 8.2 Teva Pharms
  8. 8.2.1 Teva Pharms Company Information
  9. 8.2.2 Teva Pharms Business Overview
  10. 8.2.3 Teva Pharms Lansoprazole Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharms Lansoprazole Product Portfolio
  12. 8.2.5 Teva Pharms Recent Developments
  13. 8.3 Suzhou YUSHI Pharmaceutical Co.
  14. 8.3.1 Suzhou YUSHI Pharmaceutical Co. Company Information
  15. 8.3.2 Suzhou YUSHI Pharmaceutical Co. Business Overview
  16. 8.3.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio
  18. 8.3.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Lansoprazole Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Lansoprazole Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Nang Kuang Pharmaceutical
  26. 8.5.1 Nang Kuang Pharmaceutical Company Information
  27. 8.5.2 Nang Kuang Pharmaceutical Business Overview
  28. 8.5.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio
  30. 8.5.5 Nang Kuang Pharmaceutical Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Lansoprazole Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Lansoprazole Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Luoxin Biotechnology
  38. 8.7.1 Luoxin Biotechnology Company Information
  39. 8.7.2 Luoxin Biotechnology Business Overview
  40. 8.7.3 Luoxin Biotechnology Lansoprazole Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Luoxin Biotechnology Lansoprazole Product Portfolio
  42. 8.7.5 Luoxin Biotechnology Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Lansoprazole Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Lansoprazole Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 GSK
  50. 8.9.1 GSK Company Information
  51. 8.9.2 GSK Business Overview
  52. 8.9.3 GSK Lansoprazole Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 GSK Lansoprazole Product Portfolio
  54. 8.9.5 GSK Recent Developments
  55. 8.10 Changzhou Siyao Pharmaceuticals
  56. 8.10.1 Changzhou Siyao Pharmaceuticals Company Information
  57. 8.10.2 Changzhou Siyao Pharmaceuticals Business Overview
  58. 8.10.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio
  60. 8.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
  61. 8.11 Beijing Honglin Pharma.
  62. 8.11.1 Beijing Honglin Pharma. Company Information
  63. 8.11.2 Beijing Honglin Pharma. Business Overview
  64. 8.11.3 Beijing Honglin Pharma. Lansoprazole Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio
  66. 8.11.5 Beijing Honglin Pharma. Recent Developments
  67. 8.12 Youcare Pharmaceutical Group
  68. 8.12.1 Youcare Pharmaceutical Group Company Information
  69. 8.12.2 Youcare Pharmaceutical Group Business Overview
  70. 8.12.3 Youcare Pharmaceutical Group Lansoprazole Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio
  72. 8.12.5 Youcare Pharmaceutical Group Recent Developments
  73. 8.13 Taj Pharma
  74. 8.13.1 Taj Pharma Company Information
  75. 8.13.2 Taj Pharma Business Overview
  76. 8.13.3 Taj Pharma Lansoprazole Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Taj Pharma Lansoprazole Product Portfolio
  78. 8.13.5 Taj Pharma Recent Developments
  79. 8.14 Sun Pharmaceutical Industries
  80. 8.14.1 Sun Pharmaceutical Industries Company Information
  81. 8.14.2 Sun Pharmaceutical Industries Business Overview
  82. 8.14.3 Sun Pharmaceutical Industries Lansoprazole Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio
  84. 8.14.5 Sun Pharmaceutical Industries Recent Developments
  85. 8.15 Lepu Pharmaceuticals
  86. 8.15.1 Lepu Pharmaceuticals Company Information
  87. 8.15.2 Lepu Pharmaceuticals Business Overview
  88. 8.15.3 Lepu Pharmaceuticals Lansoprazole Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio
  90. 8.15.5 Lepu Pharmaceuticals Recent Developments
  91. 8.16 Krka
  92. 8.16.1 Krka Company Information
  93. 8.16.2 Krka Business Overview
  94. 8.16.3 Krka Lansoprazole Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Krka Lansoprazole Product Portfolio
  96. 8.16.5 Krka Recent Developments
  97. 8.17 HOPE PHARMA
  98. 8.17.1 HOPE PHARMA Company Information
  99. 8.17.2 HOPE PHARMA Business Overview
  100. 8.17.3 HOPE PHARMA Lansoprazole Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 HOPE PHARMA Lansoprazole Product Portfolio
  102. 8.17.5 HOPE PHARMA Recent Developments
  103. 8.18 Dr. Reddy's
  104. 8.18.1 Dr. Reddy's Company Information
  105. 8.18.2 Dr. Reddy's Business Overview
  106. 8.18.3 Dr. Reddy's Lansoprazole Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Dr. Reddy's Lansoprazole Product Portfolio
  108. 8.18.5 Dr. Reddy's Recent Developments
  109. 8.19 Cisen Pharmaceutical
  110. 8.19.1 Cisen Pharmaceutical Company Information
  111. 8.19.2 Cisen Pharmaceutical Business Overview
  112. 8.19.3 Cisen Pharmaceutical Lansoprazole Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Cisen Pharmaceutical Lansoprazole Product Portfolio
  114. 8.19.5 Cisen Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lansoprazole Value Chain Analysis
  2. 9.1.1 Lansoprazole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lansoprazole Sales Mode & Process
  6. 9.2 Lansoprazole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lansoprazole Distributors
  9. 9.2.3 Lansoprazole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst